FDA Drug · D-0397-2026

MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7

Class I · Ongoing

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil

Affected lots / codes — check yours against thisAll codes; Exp 12/31/2029

Recalling firm: StuffbyNainax, Huntsville, TX
Classification: Class I (most serious — risk of serious harm)
Status: Ongoing
Quantity: 4
Distribution: Product was distributed to 4 customers in the US.
Recall initiated: December 15, 2025
Classified: March 18, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0397-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →